Premium Nahrungsergänzungsmittel | artgerecht

Co-trimoxazole – Antibiotic: Uses & Effects

Co-trimoxazole is a combination antibiotic containing trimethoprim and sulfamethoxazole. It is used to treat bacterial infections such as urinary tract infections and pneumonia.

Regular tips about health Regular tips about health

Things worth knowing about "Co-trimoxazole"

Co-trimoxazole is a combination antibiotic containing trimethoprim and sulfamethoxazole. It is used to treat bacterial infections such as urinary tract infections and pneumonia.

What is Co-trimoxazole?

Co-trimoxazole is a combination antibiotic composed of two active ingredients: trimethoprim and sulfamethoxazole in a fixed ratio of 1:5. The two substances work synergistically, meaning their combined effect is greater than the sum of their individual effects. Co-trimoxazole belongs to the sulfonamide class of antibiotics and has been used in medicine since the 1960s.

Mechanism of Action

Co-trimoxazole targets bacterial folic acid synthesis at two distinct steps:

Sulfamethoxazole inhibits the enzyme dihydropteroate synthase, blocking an early step in bacterial folic acid production.
Trimethoprim inhibits the enzyme dihydrofolate reductase, blocking a subsequent step in the same pathway.

Because bacteria – unlike human cells – must synthesize their own folic acid, this dual inhibition acts selectively against bacteria. Without folic acid, bacteria cannot produce DNA or essential proteins, ultimately leading to their death.

Indications

Co-trimoxazole is used to treat a wide range of bacterial infections, including:

Urinary tract infections (including acute, uncomplicated cystitis)
Respiratory tract infections (e.g., bronchitis, pneumonia caused by Pneumocystis jirovecii, especially in immunocompromised patients)
Gastrointestinal infections (e.g., traveler's diarrhea caused by susceptible bacteria)
Skin and soft tissue infections
Toxoplasmosis and other opportunistic infections in HIV-positive patients

Dosage

The standard adult dose is 960 mg of co-trimoxazole (equivalent to 160 mg trimethoprim and 800 mg sulfamethoxazole) taken twice daily. Higher doses may be used for severe infections. Co-trimoxazole is available as tablets, oral suspension, and intravenous solution. The exact dose and duration of treatment should always be determined by a healthcare professional.

Side Effects

Like all medications, co-trimoxazole can cause side effects. The most common include:

Nausea, vomiting, and diarrhea
Skin rash and allergic reactions
Blood count changes (e.g., anemia, reduced white blood cell count)
Elevated kidney values (renal stress)
Increased sensitivity to sunlight (photosensitivity)

In rare cases, serious skin reactions such as Stevens-Johnson syndrome may occur. At the first signs of severe skin changes, medical attention should be sought immediately.

Contraindications and Drug Interactions

Co-trimoxazole should not be used in patients with:

Known allergy to sulfonamides or trimethoprim
Severe liver or kidney disease
Blood cell production disorders
Newborns in the first four to six weeks of life

Important drug interactions exist with anticoagulants (blood thinners such as warfarin), methotrexate, diuretics, and certain antidiabetic medications. Concurrent use should be medically supervised.

Pregnancy and Breastfeeding

Co-trimoxazole should only be used during pregnancy – particularly in the first and third trimesters – and during breastfeeding after careful medical evaluation, as it may affect the folic acid metabolism of the infant.

Antibiotic Resistance

Due to widespread global use, some bacterial species have developed resistance to co-trimoxazole. Before initiating therapy, a susceptibility test (antibiogram) may be advisable to confirm effectiveness against the causative pathogen.

References

World Health Organization (WHO): WHO Model List of Essential Medicines, 23rd Edition, 2023.
Brunton L, Knollmann B (eds.): Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, McGraw-Hill, 2023.
European Medicines Agency (EMA): Co-trimoxazole – Summary of Product Characteristics, 2022. Available at: www.ema.europa.eu

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.